Indian state regulator revokes manufacturing suspension at Wockhardt plant
A Wockhardt facility sanctioned by Indian authorities last week has resumed production of three fixed dose combination (FDC) drugs.
Archives for April 29, 2014
Colorcon expands Indian excipients site to capture generics market
Colorcon today opened an expanded facility in Goa, India to scale up production of tablet coatings and excipients for pharmaceutical manufacturers in South Asia.
Aesica to lead £200,000 project to improve manufacturing of API
Aesica has secured a Technology Strategy Board grant to fund a high-value chemical manufacturing process with the winning process set to improve the sustainability of an active pharmaceutical Ingredient (API).
AZ picks Sinequa to index millions of R&D docs
AstraZeneca has chosen big data and analytics services provider Sinequa, to index millions of R&D documents for use in a search platform providing “sub-second” answers to research questions.
Emerging excipient markets to outpace Western markets, report says
Experts have predicted emerging Indian and Chinese markets will outpace Western markets as the $2.3bn oral solid dosage form (OSDF) excipients global market grows at a sustainable rate.
EMA issues guidance to ensure job transparency for departing staff
The European Medicines Agency (EMA) has published guidance for departing employees intended to ensure there is no conflict of interest in their new roles.